Review on Machine Learning-Driven Cervical Cancer Prediction System

Abstract

Cervical cancer ranks as one of the most common causes of death for women throughout the globe, with its highest impact found in developing nations which lack access to both routine screening and prompt diagnostic services. The conventional diagnostic methods which include Pap smears and colposcopy face challenges because they require extended durations to conduct and their implementation incurs substantial expenses and includes the possibility of human mistakes. This research introduces a machine learning-based predictive system which enables early detection of cervical cancer through analysis of patient demographic information and their medical background and laboratory examination results. The system employs data preprocessing methods together with feature extraction techniques and selection methods to address the challenges of missing data and noisy information and uneven class distribution. The researchers built and tested multiple supervised learning algorithms which included Logistic Regression Decision Tree K-Nearest Neighbors Support Vector Machine Random Forest Gradient Boosting AdaBoost and XGBoost using accuracy and precision and recall and F1-score metrics. The platform functions through Python, which establishes a simple decision support system that doctors can use to make medical decisions. The system automates prediction work while enhancing diagnostic precision, which helps doctors to identify patients early and decreases their load, while it aids in decreasing worldwide cervical cancer cases, especially in areas with limited medical facilities.

Introduction

This study reviews and analyzes the use of Artificial Intelligence (AI), Machine Learning (ML), and Deep Learning (DL) for the early detection and prediction of cervical cancer. Cervical cancer remains a major cause of mortality among women, especially in developing countries, due to limited screening facilities, delayed diagnosis, and lack of awareness. Traditional diagnostic methods such as Pap smears, HPV testing, colposcopy, and biopsies are effective but are time-consuming, labor-intensive, and dependent on expert interpretation, which can lead to diagnostic errors.

AI-based approaches offer a promising alternative by automating the analysis of medical images, clinical records, and patient risk factors. Deep learning models, particularly Convolutional Neural Networks (CNNs), have shown high accuracy in analyzing Pap smear images, colposcopy images, and histopathological slides. Traditional ML algorithms such as Logistic Regression, Random Forest, Support Vector Machine (SVM), and ensemble methods have also demonstrated strong performance in cervical cancer risk prediction while providing better interpretability.

The literature survey highlights recent advances including multimodal data integration (combining imaging, demographic, clinical, genomic, and biomarker data), Explainable AI (XAI), federated learning, lightweight edge-deployable models, and hybrid ML-DL architectures. Many studies report diagnostic accuracies exceeding 90%, with AI systems often matching or surpassing human experts in controlled environments.

Despite these advancements, several challenges remain. Most existing models are trained on small, imbalanced, or single-center datasets, limiting their generalizability. Issues such as class imbalance, lack of external validation, poor explainability, privacy concerns, regulatory barriers, and limited deployment in low-resource settings hinder clinical adoption.

The proposed methodology uses the UCI Cervical Cancer dataset containing 858 records and 36 attributes. Data preprocessing includes missing value handling, normalization, outlier removal, PCA-based dimensionality reduction, and feature selection. Multiple ML algorithms, including Logistic Regression, Decision Tree, Random Forest, SVM, KNN, AdaBoost, Gradient Boosting, and XGBoost, are evaluated using cross-validation and performance metrics such as Accuracy, Precision, Recall, F1-score, and ROC-AUC.

Conclusion

This review highlights how machine learning (ML) and deep learning (DL) technologies can transform the early detection and diagnosis and prognosis of cervical cancer. The examined research studies prove AI-based diagnostic models can reach high accuracy levels with high sensitivity and high specificity that exceed the diagnostic capabilities of Pap smear tests and colposcopy procedures. The current situation presents multiple obstacles which need to be solved. These obstacles include data imbalance and the absence of standardized datasets and the difficulties with model interpretability and the restricted testing of models in actual clinical environments. The healthcare system needs organizations to implement proper data processing methods together with effective methods to choose most important features. They need to use explainable artificial intelligence systems. Future research needs to create systems which combine different data types. The research should develop user-friendly diagnostic tools which medical professionals can use in actual healthcare environments especially in areas with limited resources. The healthcare system needs organizations to implement proper data processing methods together with effective methods to choose most important features. They need to use explainable artificial intelligence systems. The global medical community can achieve better cancer diagnosis results through AI-driven screening systems which also provide customized treatment options that lead to better patient outcomes and decreased death rates.

References

[1] B. Vázquez, M. Rojas-García, J. I. Rodríguez-Esquivel, et al., “Machine and Deep Learning for the Diagnosis, Prognosis, and Treatment of Cervical Cancer: A Scoping Review,” Diagnostics, vol. 15, no. 12, p. 1543, 2025. [2] M. Fang, B. Liao, X. Lei, and F.-X. Wu, “A systematic review on deep learning based methods for cervical cell image analysis,” Sci. Direct, 2024. [3] P. Xue, L. Dang, L.-H. Kong, H.-P. Tang, H.-M. Xu, and H.-Y. Weng, “Deep learning enabled liquid-based cytology model for cervical screening or triage,” Nat. Commun., 2025. [4] L. Liu, J. Liu, Q. Su, Y. Chu, H. Xia, and R. Xue, “Performance of artificial intelligence for diagnosing cervical cytology and colposcopy: systematic review and meta-analysis,” eClinicalMedicine, The Lancet, 2024. [5] R. Baber, N. Latif, K. Raza, U. Zaman, F. Hafsa, and F. Faiza, “Integrating Machine Learning with Pap Smear and HPV Screening,” J. Neonatal Surgery, 2024/2025. [6] L. She, Y. Li, H. Wang, and J. Zhang, “Imaging-Based AI for Predicting Lymphovascular Space Invasion in Cervical Cancer: Systematic Review and Meta-Analysis,” J. Med. Internet Res., vol. 27, p. e71091, 2025. [7] Y. Zhao, J. Cui, and L. Qiu, “Performance of artificial intelligence for diagnosing cervical intraepithelial neoplasia and cervical cancer: a systematic review and meta-analysis,” eClinicalMedicine, 2025. [8] E. E. Onuiri, C. Ogbonna, and K. C. Umeaka, “Performance of Predictive Models in Cervical Cancer Recurrence: A Systematic Review and Meta-Analysis of Biomarkers and Prognosis,” Asian J. Comput. Sci. Technol., vol. 13, no. 2, 2024. [9] Q. Wen, S. Wang, Y. Min, X. Liu, J. Fang, J. Lang, and M. Chen, “Associations of the gut, cervical, and vaginal microbiota with cervical cancer: a systematic review and meta-analysis,” BMC Women’s Health, vol. 25, p. 65, 2025. [10] C.-Q. Jiang, X.-J. Li, Z.-Y. Zhou, Q. Xin, and L. Yu, “Image-based AI models in detecting lymph node metastasis (LNM) in cervical cancer patients: Systematic Review and Meta-Analysis,” Front. Oncol., 2025.

Copyright

Copyright © 2026 Ms. Jaspreetkaur Siledar, Ms. Ashwini N. Swami. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.